Poultry Vaccine Market, By Disease (Bronchitis, Avian Influenza, Newcastle disease, Marek's Disease, and Other Diseases), By Technology (Live Attenuated Vaccines (LAV), Recombinant Vaccines, Inactivated Vaccines, and Other Technologies), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Vaccines help to prevent any particular disease by boosting the bird’s immune system to produce antibodies, which in turn, fight against a variety of organisms and diseases. A poultry vaccine help bird develop immunity to pathogens and protect them against a disease.
Market Dynamics:
Rise in prevalence/incidence of zoonotic diseases, rise in poultry population, increase in demand for safe/effective poultry, widened focus on food safety, and favorable initiatives taken by several government agencies and animal associations are major factors expected to augment growth of the global poultry vaccine market during the forecast period.
For instance, in October 2022, Zoetis expanded its poultry vaccine portfolio with the introduction of Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine which provides early and robust protection against Marek’s, infectious bursal and Newcastle disease viruses with one dose.
Moreover, in September 2019, Boehringer Ingelheim started developing the largest biotechnology production sites for the veterinary vaccine production in Europe, building on France’s pioneering expertise in veterinary public health (VPH).
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook